Singapore markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.6000+0.0300 (+0.66%)
At close: 04:00PM EST
4.6600 +0.06 (+1.30%)
After hours: 04:01PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 378.96M
Enterprise value -282.72M
Trailing P/E 13.38
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)2.00
Price/book (mrq)0.57
Enterprise value/revenue -1.47
Enterprise value/EBITDA -9.24

Trading information

Stock price history

Beta (5Y monthly) 0.18
52-week change 3-35.57%
S&P500 52-week change 3-9.85%
52-week high 39.7900
52-week low 34.1750
50-day moving average 34.6613
200-day moving average 36.3484

Share statistics

Avg vol (3-month) 3468.1k
Avg vol (10-day) 3350.84k
Shares outstanding 583.29M
Implied shares outstanding 6N/A
Float 869.56M
% held by insiders 19.11%
% held by institutions 170.21%
Shares short (12 Jan 2023) 41.66M
Short ratio (12 Jan 2023) 43.31
Short % of float (12 Jan 2023) 42.62%
Short % of shares outstanding (12 Jan 2023) 41.99%
Shares short (prior month 14 Dec 2022) 41.96M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 18.55%
Operating margin (ttm)15.83%

Management effectiveness

Return on assets (ttm)2.49%
Return on equity (ttm)5.73%

Income statement

Revenue (ttm)192.18M
Revenue per share (ttm)2.31
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)184.16M
EBITDA 30.59M
Net income avi to common (ttm)35.65M
Diluted EPS (ttm)0.3500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)664.97M
Total cash per share (mrq)7.98
Total debt (mrq)3.3M
Total debt/equity (mrq)0.50
Current ratio (mrq)43.62
Book value per share (mrq)7.96

Cash flow statement

Operating cash flow (ttm)-174.86M
Levered free cash flow (ttm)-196.87M